Prices of two DSM UHMWPE products have increased!
On February 15, 2021, DSM (DSM) announced a 15% increase in the global average price of its Dyneema® and Trosar™ UHMWPE products. The increase applies to multiple markets and applications, and will take effect on March 1, 2021, or as soon as possible within the scope of the contract terms.
In order to cope with the extreme fluctuations in raw materials, energy, global transportation and logistics costs, DSM has taken this measure, which cannot be completely offset by measures to increase productivity and reduce costs.
DSM is a goal-oriented global scientific company dedicated to nutrition, health and sustainable living.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
2026-06-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
DSM announces a new portfolio of plant-based cheeses
-
China’s API Export Shift Takes Center Stage at API China 2026
-
ECHEMI Ranks 56th on ICIS Top 100 Chemical Distributors List! A Global Leader in Chemical Supply Chain Management from Hong Kong
-
ICIS Global No.58: ECHEMI Again Ranks Among the World’s Chemical Distributors
-
Notice of 2026 Chinese New Year Holiday
-
International Workers' Day Holiday Notice and Service Arrangement
-
Supporting Each Other | ECHEMI Employees Voluntarily Raise Funds for Flood Relief in Southern Thailand
-
Address Change Declaration（ECHEMI SPECIALTIES)
-
New Location, New Horizon: ECHEMI Thailand Branch Embarks on a New Chapter
Recommend Reading
-
China National Chemical Engineering Signs 206.1 Billion Yuan in H1 2025 Contracts Top 10 Projects Surpass 290 Billion
-
Aurobindo Pharma’s $145 Million China Plant Set to Break Even by Q3 FY26 Global Expansion Gains Speed
-
Haryana’s Drug Crackdown Gets Massive Public Support State Launches Podcast to Boost Community Involvement
-
Glenmark Targets 10–15 Percent CAGR in India by Shifting to High-Margin Drugs AbbVie Deal and New Launches Boost Outlook
-
Wall Street Predicts New Obesity Pills Will Be Priced Near $1000 Like Wegovy and Zepbound Supply and Competition Pressures Mount